Contracts include funding for $91 for the Compact Air-to-Air Missile solid rocket motor and $46M for the Naval Modular Missile Quad-Pack Medium-Range motor.

BERTHOUD, Colo., Oct. 5, 2026 /PRNewswire/ -- The U.S. Navy has awarded Ursa Major two separate contracts, totaling $137 million, funded through the Office of the Under Secretary of War (OUSW), to develop and qualify advanced tactical solid rocket motors for the Compact Air-to-Air Missile (CAAM) program and the Naval Modular Missile (NMM) program. The awards leverage Ursa Major's Lynx manufacturing approach, expanding energetics production capacity and applying advanced additive manufacturing techniques to deliver tactical motors that can be produced at scale.

"By investing in CAAM and NMM, the Navy and OUSW are building solid rocket motor capacity now and getting new tactical air and naval capabilities into development sooner," said Jason Meredith, president, Solid Missile Systems at Ursa Major. "Our Lynx manufacturing approach and growing energetics capacity enable us to design, build, test, qualify and field these motors faster to support the warfighter. Production is the bottleneck in missile programs right now, and that's the part we've been building for."

For CAAM, an air-launched missile for current and next-generation aircraft, Ursa Major is designing a high-performance compact, low-cost 7-inch solid rocket motor designed to achieve performance requirements inside a tight volume and at low unit cost using Highly Loaded Grain. The design is being developed with the same manufacturing methods planned for full production, so it can be built at scale once qualified.

Ursa Major will also support the NMM medium-range variant by providing a 10-inch solid rocket motor designed for high-rate production and compatibility with existing Navy shipboard launch systems. The effort is aimed at delivering an operational motor that meets Navy performance and safety requirements while supporting high annual production volumes.

The awards build on Ursa Major's existing solid rocket motor work with the Navy. In July, the Navy awarded the company $10 million to advance its MK 104 design through critical design review and static fire testing to support the Standard Missile family. In February, Ursa Major completed a $25 million cost-share Solid Rocket Motor Manufacturing Pathfinder Program with the Navy and the Office of Strategic Capital, designing, building and static-firing a 10-inch Highly Loaded Grain motor and developing a proprietary propellant for it. That work was conducted with the Naval Air Warfare Center Weapons Division at China Lake and the Naval Surface Warfare Center Indian Head Division.

About Ursa Major

Ursa Major is an aerospace and defense company delivering flight-proven capabilities for hypersonics, solid rocket motors, and space mobility. Headquartered in Berthoud, Colorado, with additive manufacturing operations in Youngstown, Ohio, Ursa Major leverages advanced production techniques and flexible architectures to build systems for all domains: land, air, sea, and space. The company is revitalizing the defense industrial base for the U.S. and its allies, flying faster to accelerate delivery of critical capabilities where speed and adaptability matter most. For more information, visit www.ursamajor.com.

SOURCE Ursa Major

Share this article

Alavi has helped define how the world shares, moves, and listens. Now she joins Function to change how people own their health.

AUSTIN, Texas, Oct. 5, 2026 /PRNewswire/ -- Today, Function announced that Taj Alavi has joined as its first Chief Marketing Officer. Alavi will lead Function's marketing organization as the company brings a new model of health to millions more people, one where everyone can understand their biology, see how it changes over time, and take action on-time.

Alavi has built her career helping people adopt new technology as it reshaped major consumer categories. At Instagram, she led global brand marketing and launched Stories as the platform grew from 300 million to 1 billion users. She went on to lead global brand and creative at Uber. At Spotify, she served as Global Head of Marketing, leading growth, product, and marketing for a $13 billion business spanning music, podcasts, and audiobooks. At each company, she helped take something new and make it essential, building brands that hundreds of millions of people rely on and love. Most recently, she brought that experience to health, consulting at Neko Health.

"Health is a larger consumer category than music, rides, and social media combined. It has the greatest potential impact on our lives, but it's stuck in an old story that says you don't have agency," said Jonathan Swerdlin, CEO and Co-Founder of Function. "That's not true. Function is a new, direct relationship between you and your body. You have the data. You can take action. Our members are balancing hormones, preventing heart attacks, and detecting cancers early. People need to know health is finally as affordable as Spotify, as convenient as Uber, and as available as Instagram. It's Taj's turn to tell the world the new truth about health."

"I've been lucky to work on products that changed how people live every day," said Alavi. "Function is doing that for the thing that matters most. When people see what their biology is telling them for the first time, it changes how they live. My ambition is to make that level of understanding and instant action part of everyday life for millions more people."

Alavi's appointment caps a year of significant momentum for Function. Earlier this year, the company acquired Getlabs and SuppCo, partnered with NYU Grossman School of Medicine on landmark research aimed at asymptomatic disease detection, and secured $450 million in growth financing from General Catalyst's Customer Value Fund – all advancing its mission to make 100 healthy years possible for 8 billion people.

About Function

Function is on a mission to enable everyone to live 100 healthy years. A groundbreaker in its category, Function has changed the game by making lab testing, MRI and CT, and longitudinal health data accessible, understandable, and actionable – serving millions. Function's Medical Intelligence Lab™ (MI Lab™) is leveraging a dedicated clinical team to develop a continuous learning system that helps its members see, understand, and act on their biology over time. Members receive access to 160+ lab tests – including biannual testing – for just $365/year, equivalent to $1 per day, covering the heart, hormones, thyroid, liver, kidneys, heavy metal exposures, nutrient levels, inflammation, potential cancer signals, and more. Each member's results are integrated into an intelligent, personalized interface designed to support powerfully informed actions. Function members can also access (for an additional cost) MRI and CT that are designed to see signs of cancer, prior strokes, abdominal aneurysms, endometriosis, and hundreds of other conditions. Function believes it's time everyone owns their health.

SOURCE Function Health

Share this article

Nolla Health Announces Nation's First AI to Issue Initial Prescriptions

Nolla Derm helps the 90% of Utah residents who never reach a dermatologist receive AI-issued initial acne treatment within minutes, starting at $4.99 a month

SALT LAKE CITY, Oct. 5, 2026 /PRNewswire/ -- Nolla Health, the company pioneering AI-powered personal healthcare, today announced that it has become the first organization in the country to receive regulatory approval for AI to issue initial prescriptions. Starting in Utah through its Nolla Derm app, Nolla's system will prescribe acne prescriptions to help patients better access dermatology care without a waitlist, office visit, or unaffordable bill. The system is available today, and Utah residents 18 years and older can sign up here.

"AI will matter most in healthcare when it helps people get care they otherwise would not receive," said Luis Wenus, co-founder and CEO of Nolla Health. "Growing up with a doctor in the family, I saw how powerful it was to have trusted medical help within reach, and millions of people do not have that today. With Nolla Derm, we are showing how AI can responsibly expand that access and help someone get personalized treatment in minutes instead of long waits or going without care altogether. That's the future Nolla is building towards: AI helping high-quality healthcare reach far more people."

Over 80 percent of U.S. counties are considered healthcare deserts, impacting more than 120 million people, or about one in three Americans. In Utah, an estimated 100,000 people live with active acne at any given time, yet only 10 percent ever see a dermatologist. The average wait time in Utah is 61 days, nearly double the national median, with 11 counties having no dermatologists at all. People who land an appointment can pay up to $300 per visit. For patients with untreated acne, the condition can progress to permanent scarring while they wait, driving treatment costs even further.

Nolla Derm and the Utah pilot program were built to close this access gap. Following months of collaboration with the Utah Office of Artificial Intelligence, Nolla Health secured regulatory approval for the nation's first AI system authorized to issue initial prescriptions under physician oversight. Nolla Health also met and worked directly with the Utah Medical Board ahead of launch to ensure the Board's feedback was reflected in the final program.

Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols. The pilot and Nolla's AI system represent a new model for delivering routine healthcare safely, quickly, and affordably at scale, particularly for patients who may otherwise never reach a physician or specialist.

How It Works

Eligible Utah residents can download the Nolla Derm app and opt into the program for a discounted rate of $4.99 a month, a fraction of the cost of traditional healthcare. After completing an informed consent process, a 10- to 15-minute intake questionnaire, and a face scan, patients receive a personalized treatment plan and prescription directly through the app in minutes. If the AI cannot confidently select a treatment, the patient is directed to a licensed physician rather than receiving an uncertain recommendation. 

Physician oversight is built into every stage of the program:

- Stage one (first 100 patients): A licensed physician reviews and approves every AI-generated prescription before it is sent to the patient.

- Stage two (first 500 patients): Prescriptions are issued by the AI autonomously, with a physician conducting a daily retroactive review.

- Stage three: A physician retroactively reviews a sampling of prescriptions once per week.

Patients receive their prescription via home delivery or pharmacy pickup. Daily skin scans track progress over time, and treatment plans are updated monthly based on each patient's response to care. Patients can message a licensed physician directly through the app at any time – they are never speaking with AI when they reach out for support.

"The Nolla Health pilot program represents a significant step forward in leveraging AI to improve healthcare access for Utahns, while maintaining rigorous oversight and safety," said Office of Artificial Intelligence Policy Director Zach Boyd. "Our Office facilitates innovative AI solutions while ensuring that public health and patient safety remain paramount."

The pilot is designed to complement, not replace, physicians. By handling routine, low-acuity cases, Nolla Derm frees dermatologists to focus on complex, high-risk patients – including those at risk for skin cancer – and closes the access gap without burning out the doctors already stretched thin.

Built on Safety and Clinical Evidence

Developed with the Utah Office of Artificial Intelligence, the pilot underwent multiple rounds of external review by practicing physicians, dermatologists, key stakeholders, and members of the Utah government before launch. Nolla Derm's AI has already demonstrated strong clinical performance. Licensed clinicians agree with its treatment recommendations in over 96% of real-world cases, with the remaining cases reflecting minor adjustments such as topical strength modifications, not fundamental disagreements with the prescribed treatment.

Acne is the right starting point for AI in healthcare. It is a well-understood, low-risk condition with decades of clinical evidence behind it, where AI can deliver real value responsibly. Nolla Derm's system cannot generate open-ended prescriptions or improvise treatments. It can only select between pre-approved treatment pathways using structured clinical data and objective facial scan analysis.

"People are right to worry about AI in medicine that nobody can control. This program was built to be the opposite," said Dr. Zaid Fadul, Chief Medical Advisor for Nolla Health and part of the physician team overseeing the Utah pilot. "The AI can't improvise. It can only choose from a short list of physician-approved topical treatments. The moment a patient falls outside those limits, it stops and hands them to a doctor. The real test for AI in healthcare isn't how smart it is. It's whether someone other than the company can shut it off. In Utah, the state can, and physicians can - that's the standard every AI in medicine should meet."

The Nolla Derm app has been downloaded by more than 175,000 people across 44 states. To learn more, you can download the app in the App Store or visit: https://www.nollahealth.com/skincare.

About Nolla Health:

Nolla Health is an AI-powered personal healthcare company dedicated to providing clinician access and ongoing care – regardless of income or zip code. Beginning with acne and skin health, Nolla combines proprietary AI with clinician oversight to deliver diagnosis, treatment, prescriptions, and follow-up in one seamless experience. Headquartered in New York, Nolla operates across 44 states. Learn more at https://www.nollahealth.com/.

SOURCE Nolla Health

Share this article

Glacis announces Utah agreement to require verifiable AI receipts for designated sandbox systems

MOU sets mandatory evidence requirement to support independent evaluation and audit as Utah expands its clinical AI program

SALT LAKE CITY, Oct. 5, 2026 /PRNewswire/ -- Glacis Technologies Inc. today announced an agreement with Utah's Office of Artificial Intelligence Policy (OAIP) to make independently verifiable AI receipts a condition of initial and continued participation for designated vendors and systems in the state's Artificial Intelligence Learning Laboratory.

The memorandum of understanding makes generation and delivery of a cryptographically signed receipt mandatory for every covered AI inference or associated safety or governance control evaluation. Under the agreement, those receipts are generated using Glacis technology and mapped to a technical implementation based on OVERT, an open standard for verifiable evidence of AI operations.

"Clinicians and patients need to be able to verify that AI safeguards are actually running," said Joe Braidwood, founder and CEO of Glacis. "Utah's agreement puts a concrete evidence requirement behind it: a receipt for every AI decision."

OAIP determines the vendors, systems and events covered and implements the requirement through their applicable agreements or written designations. In practice, this calls for instrumenting covered workflows to generate and deliver the required records. The announcement accompanies Utah's expansion of its clinical AI program, bringing together health care organizations, clinical advisers and independent verification organizations designed to rigorously assess and verify each sandbox pilot.

The practical purpose is to give reviewers evidence from AI systems in operation. For example, a workflow may require an AI assistant to defer certain requests to a clinician. A receipt can record the configured control's reported decision for a covered event, giving an evaluator a signed record to examine alongside the clinical workflow and its results.

Coalition for Health AI (CHAI), a designated co-steward of OVERT alongside the AIGovOps Foundation, will also participate in Utah's sandbox initiative under a separate agreement.

"CHAI is thrilled to participate alongside our partner Glacis in today's news from Utah's Office of Artificial Intelligence Policy," said Brenton Hill, head of operations and general counsel at CHAI. "As a nonprofit organization founded by clinicians to advance responsible health AI, we're excited to serve as a convener of independent evaluators for the state's sandbox efforts."

Verification allows a reviewer to check the record's integrity and its association with a signing key. Determining whether the referral reached a clinician, whether the control was effective and whether the care was appropriate requires further evaluation. The receipts provide evidence for clinical oversight, evaluation and audit; they do not themselves certify safety, effectiveness or legal compliance.

The agreement also allows evidence to be linked to covered events without requiring disclosure to Glacis or OAIP of model weights, raw prompts, raw outputs or underlying personal data, unless separately agreed in writing. Hashes or other non-content identifiers may be used to make that connection.

The agreement specifies OVERT, the open technical standard developed by Glacis Technologies for verifiable evidence of AI operations. A separate framework announced in September provides for future joint stewardship of OVERT by CHAI and the AIGovOps Foundation, with Glacis as a nonvoting technical editor. OVERT remains a voluntary standard; the participation obligation described here comes from the Utah agreement and its implementing instruments.

About Glacis

Glacis builds infrastructure that helps organizations apply their rules as AI systems operate and preserves signed evidence of covered control decisions. Its technology supports independent review of those records by authorized evaluators and auditors. Learn more at glacis.io.

About OVERT

OVERT stands for Observable Verification Evidence for Runtime Trust. It is an open technical standard available under a royalty-free patent covenant. The specification and governance materials are available at overt.is.

SOURCE Glacis Technologies, Inc.

Share this article

CAMDEN, N.J., Oct. 5, 2026 /PRNewswire/ -- The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., announced today that it awarded a $260,000 Corporate Strategic grant to the National Urban League, supporting the Affiliate Movement. Funding will support workforce development programs that expand skills, education, and opportunity in communities served by American Water.

"The National Urban League is grateful to the American Water Charitable Foundation for its continued investment in our Affiliate Movement and its commitment to helping communities thrive," said Marc H. Morial, President and Chief Executive Officer, National Urban League. "This generous support will strengthen workforce development programs in cities across the country, equipping young people and adults with the skills, training, and resources they need to compete in today's economy and build brighter futures for themselves and their families. We are proud to partner with organizations like American Water that recognize that expanding opportunity is not only good for individuals, but essential to the strength and prosperity of our nation."

Founded in 1910, the National Urban League advances economic empowerment through programs focused on education, worforce and career development, housing and community development, entrepreneurship, health, and quality of life.

Through the National Urban League's Affiliate Movement, the grant will support workforce development programs delivered by the following affiliates:

- Chicago Urban League

- Greater Sacramento Urban League

- Urban League of Greater Chattanooga

- Urban League of Greater Philadelphia

- Urban League of Lexington-Fayette County

- Urban League of Metropolitan Saint Louis

- Urban League of Northwest Indiana

- Urban League of Union County

"The American Water Charitable Foundation is proud to continue its partnership with the National Urban League, supporting impactful workforce development initiatives and programming that help prepare future leaders for success," said Carrie Williams, President, American Water Charitable Foundation. "We are pleased to support organizations that help expand access to mentoring, career readiness, and workforce training opportunities for youth and young adults."

The Corporate Strategic grant is part of the Foundation's Keep Communities Flowing Grant Program, focusing on three pillars of giving: Water, People and Communities. Corporate Strategic grants support high-impact programs that align with American Water's values of being a solutions provider, where we seek to influence positive change and help keep communities flowing, improving and thriving.

Since 2012, the Foundation has invested more than $25 million in funding through grants and matching gifts to support eligible organizations in communities served by American Water.

Learn more about the American Water Charitable Foundation and the Keep Communities Flowing Grant Program here.

About American Water

American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886 and celebrating 140 years in 2026, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to approximately 14 million people with regulated operations in 14 states and on 19 military installations. American Water's approximately 7,000 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.

For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.

About American Water Charitable Foundation

The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water (NYSE: AWK), focuses on three pillars of giving: Water, People, and Communities. Since 2012, the Foundation has invested more than $25 million in funding through grants and matching gifts to support eligible organizations in communities served by American Water. The Foundation is funded by American Water shareholders and has no impact on customer rates. For more information, visit amwater.com/awcf.

SOURCE American Water

Share this article

ELEANOR, W. Va., Oct. 5, 2026 /PRNewswire/ -- West Virginia American Water is pleased to announce a $100,000 water infrastructure project on Eleanor Alley in Eleanor.

"We are excited to begin this infrastructure upgrade project in Eleanor," said Scott Wyman, President of West Virginia American Water. "Making proactive investments in the communities we serve helps us to continue providing safe, clean, and reliable water to our customers, and this project on Eleanor Alley is an example."

The project will replace 580 feet of aging pipe with 2-inch PVC main. Crews will work work along Eleanor Alley, from Cypress Street to the area behind the residence at 2371 Charleston Road. Work began the week of September 23 and is scheduled to be completed by the end of October. Final street restoration will be completed in fall 2026. Work will occur Monday through Friday between 7:30 a.m. and 5:00 p.m., and traffic restrictions will be in place for the duration of the project.

This infrastructure upgrade project is part of West Virginia American Water's plan to invest more than $129 million in ongoing infrastructure upgrades across the state in 2026, supporting the economic health of communities across the company's service area. Economic impact studies show that for every $1 million invested in water infrastructure, upwards of 10 jobs are generated throughout local economies.

Over the past decade, West Virginia American Water has invested over $805 million in infrastructure projects and capital upgrades to address aging infrastructure across the Mountain State, including more than 168 miles of new water main. To learn more about these ongoing investments, visit the company's interactive upgrade map.

During construction, customers may experience temporary service interruptions, discolored water, and/or lower than normal water pressure. Crews will work as quickly as possible to shorten the length of these temporary inconveniences. To report water related emergencies such as leaks, main breaks or other service disruptions, customers can submit a service request on the company's website.

About American Water 

American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, and celebrating 140 years in 2026, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to approximately 14 million people with regulated operations in 14 states and on 19 military installations. American Water's approximately 7,000 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.

For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.

About West Virginia American Water

West Virginia American Water, a subsidiary of American Water, is the largest regulated water utility in the state with approximately 315 dedicated employees working to provide safe, clean, reliable and affordable water and wastewater services to approximately 610,000 people.

SOURCE American Water

Share this article

A 30-year security-industry veteran joins Haven's leadership team as the company builds momentum toward Gen4's national rollout.

NASHVILLE, Tenn., Oct. 5, 2026 /PRNewswire/ -- HavenLock, Inc. today announced the appointment of Jason Lutz as Senior Vice President of Sales and Channel, the latest addition to a leadership team the company is building out as it scales toward the national rollout of its Haven Gen4 platform. Lutz brings more than three decades of security-industry leadership to the role, and will direct Haven's sales strategy, channel development, and partner engagement as the company builds out its national dealer network.

The appointment comes as Haven scales from launch into national distribution, a phase that depends on the strength of its dealer and integrator relationships as much as its product. Lutz will work directly with distributors, dealers, and systems integrators to build the channel programs and partner support Haven needs to grow, reporting to CCO, John Heller.

Lutz's arrival is the latest in a series of moves Haven has made this year to strengthen its leadership bench and channel infrastructure ahead of Gen4's national rollout — part of a broader build-out the company plans to detail further in the weeks ahead. For Haven, the hire is as much a signal of where the company is headed as it is a personnel announcement.

Lutz began his security-industry career in 1992 in sales with a national security company in Houston, Texas, before relocating to Nashville, where he spent a decade owning and operating his own security company — experience that gave him firsthand insight into the needs of installers, dealers, and end users. In 2002, he joined Resideo (formerly Ademco/Honeywell) as District Manager for the Midwest region, and over a 24-year tenure held leadership roles in National Accounts and Industry Affairs, most recently serving as Director of the company's Brand Ambassador Program, where he helped develop the next generation of security sales professionals. He has advocated for the industry on Capitol Hill and served on the Electronic Security Association Board of Directors, the Security Industry Alarm Coalition Board of Directors, the Alarm Industry Communications Committee, and the Security Industry Association Executive Advisory Board, and currently chairs Mission 500, the industry's nonprofit supporting children and communities in need.

Dealers and integrators interested in Haven's channel and certification programs can learn more at havenlock.com.

About HavenLock, Inc.

HavenLock, Inc. develops next-generation commercial access-control solutions that give dealers, facility leaders, and communities certainty at the door. Born from a veteran founder's need to protect his own family, Haven combines unyielding strength, field-tested simplicity, and accountability to the people who specify, install, and depend on its products. Learn more at havenlock.com.

Media Contact

Marie Kuhn

Chief of Staff

HavenLock, Inc.

[email protected] 

SOURCE HavenLock, Inc.

Share this article

The article explains how neighborhood choices, waterfront considerations, and lifestyle factors can help buyers make informed decisions near Buckeye Lake.

BUCKEYE LAKE, Ohio, Oct. 5, 2026 /PRNewswire/ -- The article explains that buying near Buckeye Lake is about more than finding the right house. It is also about selecting a community and lifestyle that support long-term goals. From waterfront living to quiet residential neighborhoods, the region offers a wide range of housing opportunities that appeal to first-time buyers, growing families, retirees, and those searching for a second home.

According to the HelloNation article, Buckeye Lake real estate includes everything from historic cottages and updated single-family homes to newly constructed residences and desirable lakefront homes. The variety of available properties allows buyers to match their budget, lifestyle, and future plans while taking advantage of the area's scenic setting and recreational opportunities.

The article notes that living near Buckeye Lake offers daily access to boating, fishing, kayaking, walking trails, waterfront dining, and community events, creating a welcoming atmosphere year-round. Seasonal festivals and increased lake activity during warmer months contribute to the area's unique character while helping make Buckeye Lake a destination for both full-time residents and seasonal homeowners.

The HelloNation article emphasizes that choosing the right neighborhood can be just as important as selecting the property itself. Each area surrounding the lake offers its own balance of recreation, privacy, convenience, and community involvement. Buyers who take the time to explore these differences are often better prepared to select a home that aligns with both their current lifestyle and future expectations.

Real Estate Broker Bobbi Lepi provides insights featured in the article about the practical aspects of purchasing waterfront property. The article explains that lakefront homes may require additional maintenance, including shoreline upkeep, dock care, or flood insurance depending on location. Even homes located away from the shoreline may experience seasonal traffic or benefit from nearby public access to the lake. Understanding these considerations before purchasing helps buyers make informed decisions and avoid unexpected responsibilities after closing.

The article also reviews the Buckeye Lake housing market, noting that the area's combination of recreation, natural beauty, and accessibility continues to attract buyers seeking both primary residences and vacation homes. While no real estate investment is guaranteed, the article explains that desirable recreational communities often experience steady buyer interest over time. Evaluating location, property condition, and neighborhood characteristics can help support long-term ownership goals.

The HelloNation article encourages prospective buyers to think beyond the features of an individual home and consider how the surrounding community fits their lifestyle. Those who value outdoor recreation, local events, and scenic surroundings may find Buckeye Lake especially appealing, while buyers seeking quieter neighborhoods can also find options that offer privacy yet remain close to the lake's amenities.

Ultimately, the article concludes that purchasing a home near Buckeye Lake is an investment in both property and lifestyle. By exploring neighborhoods, understanding seasonal changes, and carefully evaluating available Buckeye Lake homes, buyers can make confident decisions that support everyday living and long-term value.

Buying Near Buckeye Lake: What Every Homebuyer Should Know features insights from Bobbi Lepi, Real Estate Broker of Buckeye Lake, Ohio, in HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative "edvertising" approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article

AI-powered quantitative MRI solution enables imaging organizations to standardize body composition analysis, expand existing MRI services and create new revenue opportunities

CHICAGO, Oct. 5, 2026 /PRNewswire/ -- AIRS Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for SwiftSight® Body Composition, expanding the company's quantitative MRI platform into body composition analysis. SimonMed Imaging will be the first customer to deploy the newly cleared solution.

SwiftSight Body Composition uses AI-powered MRI analysis to quantify muscle and adipose tissue from MR images, including visceral and subcutaneous fat, abdominal and thigh muscle, muscle quality and bilateral muscle balance, along with quantitative assessment of liver fat.

SwiftSight Body Composition is designed around a scan of less than five minutes, followed by automated AI analysis. AI-driven segmentation quantifies body composition measurements, which are benchmarked against age- and sex-matched reference populations. The resulting Body Composition Report brings together quantitative measurements, percentile rankings and visual summaries in one standardized view.

"Body composition becomes more meaningful when people can track change over time, and that requires an exam that is fast and practical to repeat," said Jina Park, Chief Strategy Officer at AIRS Medical. "That is why we built SwiftSight Body Composition around a scan of less than five minutes. Whether the goal is preventive health, weight management or longevity, we want people who are taking a more active role in their health to have a quantitative measurement they can return to over time."

A 5-Minute Workflow. Built for High Volume Imaging Centers

With an MRI scan of less than five minutes and an automated scan-to-report workflow, SwiftSight Body Composition is designed to fit into high-volume MRI operations while giving health systems and imaging networks a practical way to scale quantitative body composition across their existing MRI infrastructure. Organizations can add the service without introducing a separate imaging modality or building a new manual analysis workflow.

Automated AI analysis reduces the need for manual measurement, helping imaging organizations deploy the same quantitative body composition capability across multiple locations without adding unnecessary operational complexity. This supports a more consistent patient experience across the network, with the same approach to quantitative analysis and reporting regardless of where a patient is scanned, while also supporting continuity across locations and over time.

"The next phase of MRI is not just better images, but standardized quantitative information that can scale across an imaging organization," said Ajit Shankaranarayanan, PhD, Chief Product Officer at AIRS Medical. "SwiftSight Body Composition is part of that shift. By automating the analysis of muscle, adipose tissue and liver fat, we are making advanced quantitative assessment easier to integrate into routine MRI workflows and creating a foundation for additional measurement capabilities across the SwiftSight platform."

More Than Weight or BMI

Body weight and BMI cannot show how fat and muscle are distributed throughout the body. SwiftSight provides quantitative information about visceral and subcutaneous fat, muscle quantity and quality, bilateral muscle balance and liver fat, giving healthcare professionals a more detailed view of body composition.

The solution evaluates core muscles including the abdominal wall, psoas and paraspinal muscles, as well as the quadriceps, hamstrings and adductors, including assessment of muscle proportion, quality and bilateral balance.

Liver fat is quantified using proton density fat fraction (PDFF), with automated region-of-interest measurements and visual mapping.

Supporting New MRI-Based Services

For imaging organizations, SwiftSight Body Composition also creates an opportunity to expand the value of existing MRI programs. Whole-body and preventive imaging, healthy-aging, weight-management and wellness programs can be extended with a differentiated quantitative service — creating a new revenue opportunity from MRI infrastructure already in operation.

Because MRI does not use ionizing radiation, SwiftSight can also support repeat quantitative assessment over time, allowing changes in body composition to be followed longitudinally.

For multi-site organizations, the combination of automated analysis, structured reporting and quantitative benchmarking provides a foundation for delivering a more standardized body composition experience across locations.

Expanding the AIRS Medical MRI Intelligence Platform

FDA clearance of SwiftSight Body Composition represents another step in AIRS Medical's strategy to help radiologists and imaging organizations get more performance, consistency and intelligence from the MRI infrastructure they own.

SwiftSight Body Composition expands the company's quantitative MRI portfolio beyond brain imaging and advances a broader platform strategy spanning MRI acquisition, workflow automation, quantitative analysis and longitudinal measurement.

The SwiftSight roadmap is expected to continue expanding, with diffusion tensor imaging (DTI) planned for November 2026 and quantitative joint applications planned for 2027, extending the platform into additional areas of quantitative MRI.

About AIRS Medical

AIRS Medical is an MRI intelligence company helping radiologists and imaging organizations get more performance, consistency and intelligence from the MRI infrastructure they already own. Its portfolio includes SwiftMR®, AI-powered MRI reconstruction and workflow technology, and SwiftSight®, its quantitative MRI platform.

AIRS Medical solutions are used by healthcare organizations around the world to improve MRI performance and expand the value of existing imaging infrastructure.

For more information, visit airsmed.com.

Media Contact

Cynthia Ruffino

Vice President, Marketing

AIRS Medical

[email protected]

SOURCE AIRS Medical

Share this article

CENTENNIAL, Colo., Oct. 5, 2026 /PRNewswire/ -- AlloSource®, a life sciences organization that helps restore patient functionality by transforming the gift of human tissue donation into enhanced medical products, announced the addition of UroConnex™ Fascia to its portfolio of allografts for use in women's health procedures.

UroConnex is a human fascia allograft offered in a variety of options to meet the diversity of women's health procedural needs. It comes in both freeze-dried and frozen formats, as well as a wide range of sizes to help provide structural support in the surgical site. It also streamlines urogynecological procedures and reduces patient risk by providing an alternative to using autologous fascia.

"Today marks not just the launch of a product, but a commitment to innovation and a product offering that empowers healthcare professionals and enhances patient care in Women's Health. Together, we are setting high standards for quality and excellence in every procedure," said Charles Manuele, AlloSource Senior Director, Soft Tissue Matrices.

UroConnex is a convenient, off-the-shelf fascia tissue, with a natural feel, offering ideal handling characteristics for precision placement. In addition, it is terminally sterilized through irradiation to a SAL of 10-6 to minimize risk of infection.*

In addition to UroConnex Fascia, AlloMend® Duo Acellular Dermal Matrix and AlloWrap® Amniotic Membrane are part of AlloSource's allograft portfolio that allows surgeons to support repair and reconstruction in critical women's health conditions such as pelvic organ prolapse, fistula and urinary incontinence.

For more information on AlloSource's new product UroConnex Fascia and the entire Women's Health portfolio, please visit allosource/products/urogynecology.

About AlloSource

AlloSource, a life sciences organization, helps restore patient functionality by transforming the gift of human tissue donation into enhanced medical products that enable a life of movement, health, and wellbeing. The organization partners with medical professionals and biomedical companies who share our drive for innovation and quality in the use of human tissue allografts for medical advancements. Headquartered in Centennial, Colorado, AlloSource has served a global marketplace since 1994. Learn more at allosource.org.

*Data on file at AlloSource

Media Contact

Cindy Mason

AlloSource

720. 873. 4744

[email protected]

SOURCE AlloSource

Share this article